A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor

PHI University Clinic of Dermatology, Skopje

Azienda Ospedaliera Universitaria Luigi Sacco Di Milano, Milan

University of South Florida Asthma, Allergy and Immunology Clinical Research Unit, Tampa

University of South Florida, Asthma, Allergy & Immunology Clinical Research Unit, Tampa

Washington University Division of Allergy and Immunology, St Louis

Faculty Hospital by St. Anna Brno, Department of clinical Immunology and Allergology, Brno

Baker Allergy, Asthma and Dermatology Research Center, Lake Oswego

SC Centrul Clinic Mediquest SRL, Sângeorgiu de Mureş

Ottawa Allergy Research Corp, Ottawa

Clinical Center Serbia, Belgrade